• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蓝光成像和关联色成像作为高危患者食管鳞状细胞癌的筛查模式:多中心随机试验。

Blue light imaging and linked color imaging as a screening mode for esophageal squamous cell carcinoma in high-risk patients: Multicenter randomized trial.

机构信息

Division of Gastroenterology, Tohoku University Graduate School of Medicine, Miyagi, Japan.

Department of Gastroenterology and Neurology, Akita University Graduate School of Medicine, Akita, Japan.

出版信息

Dig Endosc. 2023 Nov;35(7):835-844. doi: 10.1111/den.14538. Epub 2023 Mar 28.

DOI:10.1111/den.14538
PMID:36802097
Abstract

OBJECTIVES

Blue light imaging (BLI) and linked color imaging (LCI) are superior to conventional white light imaging for detecting esophageal squamous cell carcinoma (ESCC). Hence, we compared their diagnostic performances in ESCC screening.

METHODS

This open-labeled, randomized controlled trial was performed at seven hospitals. Patients with a high risk of ESCC were randomly assigned to the BLI group (BLI followed by LCI) and LCI group (LCI followed by BLI). The primary end-point was the detection rate of ESCC in the primary mode. The main secondary end-point was its miss rate in the primary mode.

RESULTS

In total, 699 patients were enrolled. The detection rate of ESCC did not significantly differ between the BLI and LCI groups (4.0% [14/351] vs. 4.9% [17/348]; P = 0.565); however, the number of patients with ESCC tended to be smaller in the BLI group (19 vs. 30). Notably, the miss rate of ESCC was lower in the BLI group (26.3% [5/19] vs. 63.3% [19/30]; P = 0.012) and LCI detected no ESCCs missed by BLI. The sensitivity was higher in BLI (75.0% vs. 47.6%; P = 0.042); on the other hand, the positive predictive value in BLI tended to be lower (28.8% vs. 45.5%; P = 0.092).

CONCLUSIONS

The detection rates of ESCC did not significantly differ between BLI and LCI. Although BLI may have the potential to be advantageous over LCI for the diagnosis of ESCC, it is still unclear whether BLI is superior to LCI, and a further large-scale study is needed.

TRIAL REGISTRATION

Japan Registry of Clinical Trials (jRCT1022190018-1).

摘要

目的

蓝光成像(BLI)和关联色成像(LCI)在检测食管鳞状细胞癌(ESCC)方面优于传统白光成像。因此,我们比较了它们在 ESCC 筛查中的诊断性能。

方法

这是一项在七家医院进行的开放标签、随机对照试验。高危 ESCC 患者被随机分配到 BLI 组(BLI 后行 LCI)和 LCI 组(LCI 后行 BLI)。主要终点是初始模式下 ESCC 的检出率。主要次要终点是初始模式下的漏诊率。

结果

共纳入 699 例患者。BLI 组和 LCI 组 ESCC 的检出率无显著差异(4.0%[14/351] vs. 4.9%[17/348];P=0.565);然而,BLI 组 ESCC 患者数量较少(19 例 vs. 30 例)。值得注意的是,BLI 组 ESCC 的漏诊率较低(26.3%[5/19] vs. 63.3%[19/30];P=0.012),LCI 未检测到 BLI 漏诊的 ESCC。BLI 的灵敏度较高(75.0% vs. 47.6%;P=0.042);另一方面,BLI 的阳性预测值较低(28.8% vs. 45.5%;P=0.092)。

结论

BLI 和 LCI 检测 ESCC 的检出率无显著差异。尽管 BLI 在 ESCC 诊断方面可能优于 LCI,但尚不清楚 BLI 是否优于 LCI,仍需进一步的大规模研究。

试验注册

日本临床试验注册中心(jRCT1022190018-1)。

相似文献

1
Blue light imaging and linked color imaging as a screening mode for esophageal squamous cell carcinoma in high-risk patients: Multicenter randomized trial.蓝光成像和关联色成像作为高危患者食管鳞状细胞癌的筛查模式:多中心随机试验。
Dig Endosc. 2023 Nov;35(7):835-844. doi: 10.1111/den.14538. Epub 2023 Mar 28.
2
Is blue light imaging without magnification satisfactory as screening for esophageal squamous cell carcinoma? Post-hoc analysis of multicenter randomized controlled trial.蓝光成像无放大作为食管鳞癌筛查是否满意?多中心随机对照试验的事后分析。
Dig Endosc. 2024 Oct;36(10):1118-1126. doi: 10.1111/den.14788. Epub 2024 Mar 17.
3
Impact of linked color imaging and blue laser imaging on the diagnosis of esophageal squamous cell carcinoma in iodine unstained areas.联合彩色成像和蓝色激光成像对碘未染色区域食管鳞状细胞癌诊断的影响
Kaohsiung J Med Sci. 2023 May;39(5):533-543. doi: 10.1002/kjm2.12660. Epub 2023 Feb 22.
4
Usefulness of linked color imaging in the early detection of superficial esophageal squamous cell carcinomas.链接色成像在早期检测食管浅表鳞状细胞癌中的作用。
Esophagus. 2021 Jan;18(1):118-124. doi: 10.1007/s10388-020-00749-2. Epub 2020 May 23.
5
Objective evaluation of the visibility of colorectal lesions using eye tracking.利用眼动追踪技术对结直肠病变的可视性进行客观评估。
Dig Endosc. 2019 Sep;31(5):552-557. doi: 10.1111/den.13397. Epub 2019 Apr 8.
6
Color information from linked color imaging is associated with invasion depth and vascular diameter in superficial esophageal squamous cell carcinoma.链接色成像的颜色信息与食管浅表鳞状细胞癌的浸润深度和血管直径相关。
Dig Endosc. 2020 Jan;32(1):65-73. doi: 10.1111/den.13469. Epub 2019 Oct 3.
7
Evaluation of the visibility of early gastric cancer using linked color imaging and blue laser imaging.使用联合彩色成像和蓝色激光成像评估早期胃癌的可视性
BMC Gastroenterol. 2017 Dec 8;17(1):150. doi: 10.1186/s12876-017-0707-5.
8
Linked color imaging enhances endoscopic detection of sessile serrated adenoma/polyps.联动成像增强了内镜下对无蒂锯齿状腺瘤/息肉的检测。
Endosc Int Open. 2018 Mar;6(3):E322-E334. doi: 10.1055/s-0043-124469. Epub 2018 Mar 7.
9
Detection of early stage gastric cancers in screening laser endoscopy using linked color imaging for patients with atrophic gastritis.应用连接色彩成像技术对萎缩性胃炎患者进行筛查性激光内视镜检查以早期发现胃癌。
J Gastroenterol Hepatol. 2021 Jun;36(6):1642-1648. doi: 10.1111/jgh.15312. Epub 2020 Nov 10.
10
Linked color imaging Lugol chromoendoscopy for esophageal squamous cell cancer and precancerous lesion screening: A noninferiority study.链接显色成像与卢戈氏碘染色内镜对食管鳞癌及癌前病变筛查的非劣效性研究
World J Gastroenterol. 2023 Mar 28;29(12):1899-1910. doi: 10.3748/wjg.v29.i12.1899.

引用本文的文献

1
Clinical backgrounds and outcomes of patients with Barrett's esophageal adenocarcinoma treated via endoscopic submucosal dissection in Kyushu, Japan: A retrospective multicenter cohort study.日本九州地区经内镜黏膜下剥离术治疗的巴雷特食管腺癌患者的临床背景及预后:一项回顾性多中心队列研究
DEN Open. 2025 May 5;6(1):e70102. doi: 10.1002/deo2.70102. eCollection 2026 Apr.
2
Surveillance for metachronous cancers after endoscopic resection of esophageal squamous cell carcinoma.食管鳞状细胞癌内镜切除术后异时性癌的监测
Clin Endosc. 2024 Sep;57(5):559-570. doi: 10.5946/ce.2023.263. Epub 2024 May 10.